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INTRODUCTION 
Commercial duck farming in Indonesia is 
practiced either as a nomadic way (moving 
around) or as an intensified settled system. Since 
the emergence of Highly Pathogenic Avian 
Influenza (HPAI) H5N1 subtype clade 2.1.3 in 
Indonesia in 2003, ducks acted as a reservoir 
(carrier) without showing clinical signs. In late 
2012 the new HPAI H5N1 clade 2.3.2 was 
introduced which caused high duck mortality, 
especially in young ducks. Nomadic ducks have a 
high risk of developing and spreading Avian 
Influenza (AI). In addition to this high risk, there 
are many duck farmers who do not practice proper 
AI vaccination, to achieve protective immunity. 
One of the measures to control AI is by 
administering scheduled vaccinations. The 
objective of this study was to investigate the 
increase of AI antibody titer in ducks after 
vaccination and to identify the best timing for 
vaccination. 
 
MATERIALS AND METHODS 
This study was conducted from March to 
July 2018 in Mojokerto district. The ducks in this 
study were categorized into two groups; ducks in 
group A were vaccinated twice, while ducks in 
group B were vaccinated 3 times using H5N1 
monovalent clade 2.3.2 vaccine. Meanwhile, based 
on the age of ducks at the beginning of the sampling 
was divided into 3 groups, i.e. 4 weeks (group 1), 
14 and 16 weeks, and 22 and 26 weeks (group 3). 
Five sentinel ducks (unvaccinated ducks) 
were placed in each farm to monitor the circulation 
of AI in the environment. Sera were collected from 
each flock for Hemagglutination Inhibition (HI) 
testing before vaccination and at monthly intervals 
after vaccination. Samples were collected 
randomly from 20 vaccinated ducks and from the 5 
sentinel ducks. The antibody titer test was 
performed in the virology laboratory of the Faculty 
of Veterinary Medicine of Airlangga University. In 
addition to blood serum samples, tracheal and 
cloacal swab samples and pooled drinking water 
and environmental swab samples were collected. 
Testing of the swab samples was performed at the 
Disease Investigation Center Wates.  
 
RESULT AND DISCUSSION 
From the result of AI antibody titer test, 
the initial status of AI antibody titer protective 
level of titer 24 or more, for sentinel ducks by 19%, 
whereas for treatment ducks A and B by 14%. After 
the first vaccination, protective titers were shown 
in 29% sentinel ducks while 58% of treatment A 
and B ducks showed 58% protection. One month 
after the second vaccination, protective titers of 
sentinel ducks increased to 62%, while ducks with 
treatment A and B improved to 79%. Protective 
antibody titers for ducks in group B, following 3 AI 
vaccinations, reached 83%, with sentinel ducks 
achieving to 60% protection rate. 
From the Figure 1, vaccine treatment 2 
times and 3 times does not give a significant 
difference. Meanwhile, when viewed based on age 
groups, the increase in antibodies in ducks with 
different age levels can be seen in Figure 2. 
 
 
Figure 1. Improvement of duck antibody titer (%) 
 
From the Figure 2, Group 2 (age 14 and 16 
weeks) provided maximum protection of 100% 
when compared to group 1 (age 4 weeks) at 59% 
and group 3 (over 22 weeks) at 80% after 2 times 
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vaccination. Whereas in sentinel ducks, it was 
shown that the antibody titers in group 3 at the 
beginning of taking were 67% but had decreased in 
subsequent sampling by 36% and 20%. In group 1, 
the initial and second sentinel titers were 0 and the 
third was 67%, whereas in group 2 the initial titer 
of sentinel was 0 and the subsequent titers were 
33% and 69%. 
Figure 2. Duck antibody titer by age (%) 
 
Antibody titers in sentinel ducks were 
probably a result of natural infection or f AI virus 
circulating in the farm environment; PCR testing 
for H5 and H9, gave negative result. This may occur 
due to low biosecurity standards in duck farming 
systems and the nomadic duck rearing system, 
which is a risk factor for AI spread. There were no 
clinical signs of AI in duck farms that had high AI 
antibody titers in sentinel ducks. The reason for 
farmers using nomadic farming for ducks over one 
month of age is to save on food cost.     
The data demonstrates that proper on 
schedule AI vaccination, the use of appropriately 
matched vaccine and appropriate vaccination 
techniques, will provide immunity of AI to 100% 
(Figure 2).   
The unvaccinated duckling system has a 
risk of AI incidence that cause decrease in 
production, of premature spent duck without 
vaccination. This was in line with the study 
conducted by Henning et al. (2016) which stated 
that characteristics of the moving duck production 
system indicate that it may pose a high risk for the 
maintenance and transmission of HPAI H5N1. 
Indriani et al. (2014) also state that ducks that 
were tested with HPAI H5N1 clade 2.3.2 had 67% 
protection compared to unvaccinated ducks (0% 
protection).  
Vaccination is one tool to control AI in 
ducks but it is not the only way to prevent AI 
occurrence in livestock; other ways are include 
integrated measures such as improved strict 
biosecurity (3 zones biosecurity) and better flock 
management. 
CONCLUSION 
Two monthly scheduled vaccinations of 
ducks at 14-16 weeks of age using a full dose of 
H5N1 clade 2.3.2 vaccine before the production 
periods, will provide 100% protection. 
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